Karnataka
News Category

1win Charity's $170,000 Investment in India Signals Long-Term Community Commitment
1win Charity has directed over $170,000 to projects in India supporting elderly care, sports infrastructure, disaster recovery, and environmental rest...

Lantern Pharma Reports Q2 2026 Results, Highlights AI Oncology Progress and OMAI Spin-off
Lantern Pharma's Q2 2026 results show reduced operating losses and promising clinical data, while the establishment of Open Medicine AI as a separate ...

Lantern Pharma Schedules Q2 2026 Results Webcast, Highlighting AI-Driven Oncology Progress
Lantern Pharma's upcoming webcast to discuss Q2 2026 results underscores its strategic focus on AI-driven drug development and commercialization of it...

Lantern Pharma Receives U.S. Patent Allowance for LP-184 Biomarker-Based Cancer Treatment Methods
Lantern Pharma obtained a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for its investigational therapy ...

Formycon and OneSource Specialty Pharma Form Strategic Manufacturing Partnership for Biosimilars
Formycon AG and OneSource Specialty Pharma have announced a strategic manufacturing partnership to produce biosimilars, leveraging OneSource's integra...

Lantern Pharma Launches ZetaOmics, an AI-Powered Computational Biology Platform, Expanding Commercial Opportunities Beyond Rare Cancers
Lantern Pharma launched ZetaOmics, an AI-driven computational biology platform that automates multi-omic analysis and research workflows, targeting ac...

Academy Hunt Expands AI Course Comparison Database to Over 1,000 Listings
Academy Hunt has expanded its platform to include over 1,000 AI course comparisons, helping students and professionals evaluate training options acros...

Quantum Genesis AI Clarifies Research Ties and Intellectual Property Ownership
Quantum Genesis AI Corp. issued a statement to distinguish its research activities from those of Quantumzyme LLP and clarify intellectual property rig...

Lantern Pharma Raises $4.4 Million in Registered Direct Offering to Advance AI-Driven Precision Oncology Pipeline
Lantern Pharma closed a $4.4 million registered direct offering, providing capital to support its clinical pipeline and AI platform, underscoring its ...


